1. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis.
Brain, 2022
Riva, N., Gentile, F., Cerri, F., (…), Corbo, M., Filippi, M., Quattrini, A.
2. Predicting home discharge after inpatient rehabilitation of stroke patients with aphasia.
Neuropsychological Rehabilitation, 2022
Ginex, V., Viganò, M., Gilardone, G., Monti, A., Gilardone, M., Corbo, M.
3. An overview of the therapeutic effects of curcumin in reproductive disorders with a focus on the antiinflammatory and immunomodulatory activities.
Phytotherapy Research, 2022
Saifi, B., Haftcheshmeh, S.M., Feligioni, M., (…), Mohammadi, A., Sahebkar, A.
4. Brain Connectivity and Graph Theory Analysis in Alzheimer’s and Parkinson’s Disease: The Contribution of Electrophysiological Techniques.
Brain Sciences, 2022
Miraglia, F., Vecchio, F., Pappalettera, C., (…), Judica, E., Ferreri, F., Rossini, P.M.
5. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Nature Genetics, 2022
van Rheenen W., van der Spek R.A.A., Bakker M.K., (…), SLALOM Consortium, PARALS Consortium, SLAGEN Consortium, SLAP Consortium
6. Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder.
Pattern Recognition, 2022
Liu, S., Han, J., Puyal, E.L., ( …), Comi, G., Schuller, B., Consortium, R.A.D.A.R.-C.N.S.
7. Molecular and clinical implications of variant repeats in myotonic dystrophy type 1.
International Journal of Molecular Sciences, 2022
Peric, S., Pesovic, J., Savic-Pavicevic, D., Stojanovic, V.R., Meola, G.
8. Patient Perception When Transitioning from Classic to Remote Assisted Cardiac Rehabilitation
Diagnostics, 2022
Busnatu, Ș.-S., Pană, M.-A., Lăcraru, A.E., Caprino, M.; (…), Andrei, C.L., Sinescu, C.-J.
9. Improving reproducibility of motor evoked potentials in mice
Journal of Neuroscience Methods, 2022
Castoldi, V., Rossi, E., Marenna, S., Comi, G., Leocani, L.
10. Intensive Neurorehabilitation and Gait Improvement in Progressive Multiple Sclerosis: Clinical, Kinematic and Electromyographic Analysis
Brain Sciences, 2022
Huang, S.-C., Guerrieri, S., Costa, G.D., (…), Comi, G., Leocani, L.
11. Dose-dependent effect of myelin oligodendrocyte glycoprotein on visual function and optic nerve damage in experimental autoimmune encephalomyelitis
Journal of Neuroscience Research, 2022
Castoldi, V., Marenna, S., Huang, S.-C., (…), Comi, G., Leocani, L.
12. Cross-cultural adaptation into Italian and validation of the Frenchay dysarthria assessment – 2
European Journal of Physical and Rehabilitation Medicine, 2022
Riolo V., Pizzorni N., Guanziroli E., Agostinis B., Confortola M., Schettino N., Gilardone G., Schindler A., Molteni F.
13. One-year cognitive follow-up of COVID-19 hospitalized patients
European Journal of Neurology, 2022
Ferrucci, R., Dini, M., Rosci, C., (…), Monti, A., Ticozzi N., Silani, V., Centanni, S., D’Arminio Monforte, A., Tagliabue, L., Priori, A.
14. Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial
European Journal of Neurology, 2022
Vermersch, P., Oreja-Guevara, C., Siva, A., (…), Kuenzel, T., Comi, G.
15. Acid-Base Disorders in COVID-19 Patients with Acute Respiratory Distress Syndrome
Journal of Clinical Medicine, 2022
Chiumello, D., Pozzi, T., Fratti, I., (…), Papa, G.F.S., Coppola, S.
16. Performance prediction in a visuo-motor task: the contribution of EEG analysis
Cognitive Neurodynamics, 2022
Vecchio, F., Alù, F., Orticoni, A., (…), Judica, E., Cotelli, M., Rossini, P.M.
17. Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes
Frontiers in Neuroscience, 2022
Marenna S., Huang S.-C., Dalla Costa G., d’Isa R., Castoldi V., Rossi E., Comi G., Leocani L.
18. Role of hyperpnea in the relaxant effect of inspired CO2 on methacholine-induced bronchoconstriction
Journal of Applied Physiology, 2022
Torchio R., Gobbi A., Gulotta C., Antonelli A., Dellacà R., Pellegrino G.M., Pellegrino R., Brusasco V.
19. Role of hyperpnea in the relaxant effect of inspired CO2 on methacholine-induced bronchoconstriction
Multiple Sclerosis and Related Disorders, 2022
Zaratin, P., Vermersch, P., Amato, M.P., (…), Baneke, P., Comi, G.
20. Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
Frontiers in Neurology, 2022
Peric, S., Zlatar, J., Nikolic, L., (…), Meola, G., Rakocevic-Stojanovic, V.
21. Case report: Sodium and chloride muscle channelopathy coexistence: A complicated phenotype and a challenging diagnosis
Frontiers in Neurology, 2022
Pagliarani, S., Meola, G., Filareti, M., Comi, G.P., Lucchiari, S.
22. The Reaching Phase of Feeding and Self-Care Actions Optimizes Action Observation Effects in Chronic Stroke Subjects
Neurorehabilitation and Neural Repair, 2022
Franceschini M., Ottaviani M., Romano P., Goffredo M., Pournajaf S., Lofrumento M., Proietti S., Sterpi I., Tricomi E., Tropea P., Corbo M., Fadiga L., Infarinato F.
23. A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis
Journal of Neurology, 2022
Lunetta C., Lizio A., Cabona C., Gerardi F., Sansone V.A., Corbo M., Scialò C., Angelucci E., Gualandi F., Marenco P., Grillo G., Cairoli R., Cesana C., Saccardi R., Melazzini M.G., Mancardi G., Caponnetto C.
24. Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol
PLoS ONE, 2022
Mikolaizak A.S., Rochester L., Maetzler W., (…) Comi G., Leocani L., Helbostad J.L., Johnsen L.G., Taraldsen K., Blain H., Driss V., Frei A., Puhan M.A., Polhemus A., de Basea M.B., Gimeno E., Hopkinson N.S., Buttery S.C., Hausdorff J.M., Mirelman A., Evers J., Neatrour I., Singleton D., Schwickert L., Becker C., Jansen C.-P., (WP4) on behalf of Mobilise-D consortium
25. Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
Multiple Sclerosis Journal, 2022
Cree B.A.C., Selmaj K.W., Steinman L., Comi G., Bar-Or A., Arnold D.L., Hartung H.-P., Montalbán X., Havrdová E.K., Sheffield J.K., Minton N., Cheng C.-Y., Silva D., Kappos L., Cohen J.A.
26. A Plasma Circular RNA Profile Differentiates Subjects with Alzheimer’s Disease and Mild Cognitive Impairment from Healthy Controls
International Journal of Molecular Sciences, 2022
Piscopo P., Manzini V., Rivabene R., Crestini A., Le Pera L., Pizzi E., Veroni C., Talarico G., Peconi M., Castellano A.E., D’Alessio C., Bruno G., Corbo M., Vanacore N., Lacorte E.,
27. A systematic review on drugs for synaptic plasticity in the treatment of dementia
Ageing Research Reviews, 2022
Piscopo P., Crestini A., Carbone E., Rivabene R., Ancidoni A., Lo Giudice M., Corbo M., Vanacore N., Lacorte E.,
28. Costs and effects of telerehabilitation in neurological and cardiological diseases: A systematic review
Frontiers in Medicine, 2022
Del Pino, R., Díez-Cirarda, M., Ustarroz-Aguirre, I., (…), Caprino, M., Gabilondo, I., Gómez-Esteban, J.C.
29. Electroencephalographic hallmarks of Alzheimer’s disease
International Journal of Psychophysiology, 2022
Ferreri F., Miraglia F., Vecchio F., Manzo N., Cotelli M., Judica E., Rossini P.M.
30. End Users’ and Other Stakeholders’ Needs and Requirements in the Development of a Personalized Integrated Care Platform (PROCare4Life) for Older People With Dementia or Parkinson Disease: Mixed Methods Study
JMIR Formative Research, 2022
Ahmed, M., Marín, M., Judica, E., Tropea, P., (….), Bouça-Machado, R., Brach, M.
31. Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study
Neurological Sciences, 2022
Baroncini D., Ghezzi A., Guaschino C., (…), Comi G., Zaffaroni M., Trojano M., Centonze D., Capra R., Capobianco M., Laroni A., Uccelli A., Gallo A., Patti F., Danni M.C., Gasperini C., Coniglio G., MS Study Group of the Italian Neurological Society
32. Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson’s and Huntington’s disease
Frontiers in Aging Neuroscience, 2022
Poletti B., Solca F., Maffi S., Torre S., Carelli L., Aiello E.N., Ferrucci R., Priori A., Monti A., Verde F., Ticozzi N., Migliore S., Scaricamazza E., Casella M., Squitieri F., Ciammola A., Silani V.
33. Transcranial direct current stimulation as a preventive treatment in multiple sclerosis? Preclinical evidence
Experimental Neurology, 2022
Marenna S., Huang S.-C., Rossi E., Castoldi V., Comi G., Leocani L.,
34. A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes
Neurological Sciences, 2022
Bellomo G., Piscopo P., Corbo M., Pupillo E., Stipa G., Beghi E., Vanacore N., Lacorte E.,
35. Anterior optic pathway pathology in CNS demyelinating diseases
Brain , 2022
Pisa, M., Pansieri, J., Yee, S., …Leocani, L., DeLuca, G.Comi
36. Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis
Journal of Clinical Medicine, 2022
Siddi S., Giné-Vázquez I., Bailon R., Matcham F., Lamers F., Kontaxis S., Laporta E., Garcia E., Arranz B., Dalla Costa G., Guerrero A.I., Zabalza A., Buron M.D., Comi G., Leocani L., (…), Myin-Germeys I., Haro J.M., PAB Members, on behalf of the RADAR-CNS Consortium
37. Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
Communications Biology, 2022
Šušnjar, U., Škrabar, N., Brown, A.-L., (…), Meola, G., Ripolone M., Moggio, M., Secrier, M., Fratta, P., Buratti, E.
38. New Insights into Dose-Dependent Effects of Curcumin on ARPE-19 Cells
International Journal of Molecular Sciences, 2022
Carozza G., Tisi A., Capozzo A., Cinque B., Giovannelli A., Feligioni M., Flati V., Maccarone R.,
39. Syntaxin-1a and SNAP-25 expression level is increased in the blood samples of ischemic stroke patients
Scientific Reports, 2022
Cappelletti P., Filareti M., Masuelli L., Bei R., Hassanzadeh K., Corbo M., Feligioni M.
40. The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions
Computer Methods and Programs in Biomedicine, 2022
Sun S., Folarin A.A., Zhang Y., Cummins N., Liu S., (…), Comi G., Dobson R.J., RADAR-CNS consortium
41. Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: A study from the Italian MS Register
Multiple Sclerosis Journal, 2022
Iaffaldano P., Lucisano G., Guerra T., (…), Comi G., Filippi M., Amato M.P., Trojano M.,
42. Disease stability over five years in people with multiple sclerosis treated with cladribine tablets: a plain language summary of publication
Neurodegenerative Disease Management, 2022
Giovannoni, G., Comi, G., Rammohan, K., (…), Jack, D., Vermersch, P.
43. Signs and symptoms of COVID-19 in patients with multiple sclerosis
European Journal of Neurology, 2022
Schiavetti, I., Carmisciano, L., Ponzano, M., (…), Comi, G., Zito, A., Zuliani, L.
44. Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
Expert Review of Clinical Immunology., 2022
Dalla Costa, G., Leocani, L., Comi, G.
45. Post-stroke acquired childhood aphasia. A scoping review
Child Neuropsychology, 2022
Gilardone, G., Viganò, M., Cassinelli, D., (…), Sozzi, M., Corbo, M.
46. Protective Effect of Curcuma Extract in an Ex Vivo Model of Retinal Degeneration via Antioxidant Activity and Targeting the SUMOylation
Oxidative medicine and cellular longevity, 2022
Hassanzadeh K., Vahabzadeh Z., Bucarello L., Dragotto J., Corbo M., Maccarone R., Feligioni M.
47. Reliable change indices for the Italian Edinburgh Cognitive and Behavioral ALS Screen (ECAS)
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 2022
Aiello E.N., Solca F., Torre S., Carelli L., Monti A., Ferrucci R., Verde F., Ticozzi N., Silani V., Poletti B.,
48. Safety and Efficacy of Monoclonal Antibodies for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials
Journal of Alzheimer’s Disease, 2022
Lacorte E., Ancidoni A., Zaccaria V., Remoli G., Tariciotti L., Bellomo G., Sciancalepore F., Corbo M., Lombardo F.L., Bacigalupo I., Canevelli M., Piscopo P., Vanacore N.,
49. Let Time Teach You: A Case Report of a Double Diagnosis of 17P Duplication and Ehlers-Danlos Syndrome
Genes, 2022
Castronovo, P., Aleo, S., Seresini, A., Brunati, E., (…), Guez, S., Milani, D.
50. The Italian Aphasia Awareness Survey (IAAS): an online questionnaire about the public knowledge of aphasia in Italy, informative findings
Aphasiology, 2022
Viganò, M., Gilardone, G., Cassinelli, D., (…), Corbo, M., Monti, A.
51. Clinical score for early diagnosis of myotonic dystrophy type 2
Neurological Sciences, 2022
Ivanovic, V., Peric, S., Pesovic, J., (…), Meola, G., Rakocevic-Stojanovic, V.
52. Prevalence and determinants of language impairment in non-demented amyotrophic lateral sclerosis patients
European Journal of Neurology, 2022
Solca, F., Aiello, E.N., Torre, S., (…), Monti, A., Poletti, B.
53. The Semantic Association Test (SAT): normative data from healthy Italian participants and a validation study in aphasic patients
Neurological Sciences, 2022
Banco, E., Veronelli, L., Briguglio, M., Luzzatti, C., Vallar, G.
54. AGREE: an upper-limb robotic platform for personalized rehabilitation, concept and clinical study design
IEEE International Conference on Rehabilitation Robotics, 2022
Gasperina S.D., Longatelli V., Panzenbeck M., Luciani B., Morosini A., Piantoni A., Tropea P., Braghin F., Pedrocchi A., Gandolla M.
55. Editorial: Neurodegeneration: From Disease Mechanism to Therapeutic Advancement
Frontiers in Genetics, 2022
Sarkar, P.S., Meola, G., Zhang, N.
56. Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-β
Multiple Sclerosis and Related Disorders, 2022
Simpson-Yap, S., Pirmani, A., De Brouwer, E., (…), Comi, G., Kalincik, T.
57. Emerging trends in multiple sclerosis research
Multiple Sclerosis and Related Disorders, 2022
Dalla Costa G., Comi G.
58. Synaptosomal Preparation and Its Application in Preclinical Studies
Neuromethods, 2022
Feligioni M., Buccarello L., Hassanzadeh K., Corbo M.